Prior to this role, from November 2022 to October 2023, she worked at the Clinical Investigation Center of the University Hospital of Toulouse, providing methodological support for care teams in pneumology, internal medicine, and oncology. She also participated in methodological appraisals of national and inter-regional projects.
She completed her Pharmacy thesis on protein kinase inhibitors for lung cancer management during this time. In January 2022 to July 2022, she undertook a Master 2 internship at the CESP (Center for Epidemiology and Population Health Research) – Epiphare, focusing on identifying factors associated with severe SARSCoV2 infection in multiple sclerosis patients using the National Health Data System.
In May 2021 to November 2021, she worked in the Pharmacovigilance Department of the pharmaceutical company Merck, analyzing pharmacovigilance cases and participating in implementing recommendations for ovitrelle use in men.
Earlier experiences include working in the oncology department of the University Hospital of Toulouse from November 2020 to April 2021, and in various pharmacovigilance centers and clinical pharmacy settings. Additionally, from November 2018 to April 2019, she worked in the medical device purchasing department at Toulouse University Hospital, contributing to the implementation of call for tenders.